Download full report with analyst certification and important disclosures
May 30 2025, 07:14 IST/BST
hVIVO has announced that it has received notification of a significant contract cancellation alongside a postponement and a cancellation of a smaller study. This is due to uncertainty in the pharmaceutical sector and biotech financing, especially in the US. This has impacted FY2025 guidance.
May 30 2025, 07:14 IST/BST